Free Trial
NYSEARCA:XBI

SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

SPDR S&P Biotech ETF logo
$82.56 +0.08 (+0.10%)
Closing price 04:10 PM Eastern
Extended Trading
$82.32 -0.24 (-0.29%)
As of 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SPDR S&P Biotech ETF (NYSEARCA:XBI)

Key Stats

Today's Range
$81.42
$83.33
50-Day Range
$69.80
$83.50
52-Week Range
$66.66
$105.47
Volume
8.09 million shs
Average Volume
9.26 million shs
Market Capitalization
$4.89 billion
Assets Under Management
$5.00 billion
Dividend Yield
0.17%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

SPDR S&P Biotech ETF Expenses

TypeXBIHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.57%0.57%0.52%0.53%
Other Expenses0.00%0.30%0.48%0.56%0.51%
Total Expense0.35%0.70%0.72%0.73%0.71%
Fee Waiver0.00%-0.45%-0.49%-0.65%-0.54%
Net Expense0.35%0.61%0.63%0.58%0.60%
Receive XBI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Biotech ETF and its competitors with MarketBeat's FREE daily newsletter.

XBI ETF News Headlines

The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Revolution we predicted has arrived." In fact, I believe these robots could impact 65 million Americans lives — by August of this year.
SPDR S&P Biotech ETF Experiences Big Inflow
Friday's ETF Movers: XBI, COPX
See More Headlines

XBI ETF - Frequently Asked Questions

SPDR S&P Biotech ETF's stock was trading at $90.06 at the start of the year. Since then, XBI stock has decreased by 8.3% and is now trading at $82.56.
View the best growth stocks for 2025 here
.

SPDR S&P Biotech ETF's top institutional shareholders include Goldman Sachs Group Inc. (21.29%), JPMorgan Chase & Co. (16.32%), Jane Street Group LLC and Demars Financial Group LLC (4.94%).

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Biotech ETF investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and Humana (HUM).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Biotech ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XBI
Inception Date
1/31/2006
Fund Manager
Michael Feehily, Karl Schneider, Raymond Donofrio

Fund Focus

Asset Class
Equity
Benchmark
S&P Biotechnology Select Industry Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
157

Fund Statistics

Assets Under Management
$5.06 billion
Average Daily Volume
$12.97 million
Discount/Premium
0.02%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
42,480
Put Options
12,693
Call Options
29,787
Short Interest
73,560,000 shs

Miscellaneous

Beta
0.85
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Top 10 XBI Holdings


This page (NYSEARCA:XBI) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners